| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | autosomal dominant polycystic kidney disease | PKD2* | Pkd2* | 1 model | Alliance of Genome Resources | ||
| autosomal dominant pseudohypoaldosteronism type 1 | NR3C2* | Nr3c2* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | PKHD1* | Pkhd1* | 6 models | Alliance of Genome Resources | |||
| Bartter disease type 1 | SLC12A1* | Slc12a1* | 2 models | Alliance of Genome Resources | |||
| Bartter disease type 2 | KCNJ1* | Kcnj1* | 1 model | Alliance of Genome Resources | |||
| Bartter disease type 3 | CLCNKB*, CLCNKA | Clcnkb*, Clcnka | 1 model | Alliance of Genome Resources | |||
| Bartter disease type 4a | BSND* | Bsnd* | 2 models | Alliance of Genome Resources | |||
| congenital megabladder | MYOCD* | Myocd* | 2 models | Alliance of Genome Resources | |||
| cystinuria | SLC3A1* | Slc3a1* | 4 models | Alliance of Genome Resources | |||
| cystinuria | SLC7A9* | Slc7a9* | 2 models | Alliance of Genome Resources | |||
| familial juvenile hyperuricemic nephropathy | UMOD* | Umod* | 2 models | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis 1 | ACTN4* | Actn4* | 1 model | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis 2 | TRPC6* | Trpc6* | 3 models | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis 3 | CD2AP* | Cd2ap* | 1 model | Alliance of Genome Resources | |||
| Gitelman syndrome | SLC12A3* | Slc12a3* | 2 models | Alliance of Genome Resources | |||
| hemolytic-uremic syndrome | CFH* | Cfh*, Cfhr4 | 1 model | Alliance of Genome Resources | |||
| IgA glomerulonephritis | SCGB1A1* | Scgb1a1* | 2 models | Alliance of Genome Resources | |||
| karyomegalic interstitial nephritis | FAN1* | Fan1* | 3 models | Alliance of Genome Resources | |||
| Liddle syndrome | SCNN1B* | Scnn1b* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | AQP2* | Aqp2* | 4 models | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | AVPR2* | Avpr2* | 2 models | Alliance of Genome Resources | |||
| nephronophthisis 1 | NPHP1* | Nphp1* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis 2 | INVS* | Invs* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis 3 | NPHP3* | Nphp3* | 2 models | Alliance of Genome Resources | |||
| nephronophthisis 4 | NPHP4* | Nphp4* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis 7 | GLIS2* | Glis2* | 1 model | Alliance of Genome Resources | |||
| neurohypophyseal diabetes insipidus | AVP* | Avp* | 2 models | Alliance of Genome Resources | |||
| polycystic kidney disease 1 | PKD1* | Pkd1* | 27 models | Alliance of Genome Resources | |||
| polycystic kidney disease 2 | PKD2* | Pkd2* | 7 models | Alliance of Genome Resources | |||
| polycystic kidney disease 4 | PKHD1* | Pkhd1* | 2 models | Alliance of Genome Resources | |||
| pseudohypoaldosteronism | KLHL3* | Klhl3* | 4 models | Alliance of Genome Resources | |||
| pseudohypoaldosteronism | WNK4* | Wnk4* | 1 model | Alliance of Genome Resources | |||
| renal tubular acidosis | SLC4A1* | Slc4a1* | 1 model | Alliance of Genome Resources | |||
| renal tubular acidosis | SLC4A4* | Slc4a4* | 1 model | Alliance of Genome Resources | |||
| renal tubular acidosis | ATP6V0A4* | Atp6v0a4* | 1 model | Alliance of Genome Resources | |||
| urinary bladder cancer | PTEN* | Pten* | 3 models | Alliance of Genome Resources | |||
| X-linked nephrogenic diabetes insipidus | AVPR2* | Avpr2* | 1 model | Alliance of Genome Resources | |||
| | autosomal dominant polycystic kidney disease | BICC1 | Bicc1* | 1 model | Alliance of Genome Resources | ||
| autosomal dominant polycystic kidney disease | MYC | Myc*, Bmyc | 1 model | Alliance of Genome Resources | |||
| autosomal dominant polycystic kidney disease | NPHP3 | Nphp3* | 3 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | ARL3 | Arl3* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | DZIP1L | Dzip1l* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | IFT88 | Ift88* | 4 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | NEK1 | Nek1* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | NEK8 | Nek8* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | PKD1 | Pkd1* | 2 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | SCLT1 | Sclt1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | TSC1 | Tsc1* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | BICC1 | Bicc1* | 6 models | Alliance of Genome Resources | |||
| autosomal recessive polycystic kidney disease | CYS1 | Cys1* | 5 models | Alliance of Genome Resources | |||
| autosomal recessive pseudohypoaldosteronism type 1 | SCNN1B | Scnn1b* | 1 model | Alliance of Genome Resources | |||
| autosomal recessive pseudohypoaldosteronism type 1 | SCNN1G | Scnn1g* | 1 model | Alliance of Genome Resources | |||
| Bartter disease | CLCNKA, CLCNKB | Clcnkb*, Clcnka | 1 model | Alliance of Genome Resources | |||
| bilateral renal aplasia | NPNT | Npnt* | 1 model | Alliance of Genome Resources | |||
| bladder exstrophy | TP63 | Trp63* | 1 model | Alliance of Genome Resources | |||
| CAKUT | ZNG1A, ZNG1B, ZNG1C, ZNG1E, ZNG1F | Zng1* | 2 models | Alliance of Genome Resources | |||
| CAKUT | LIFR | Lifr* | 1 model | Alliance of Genome Resources | |||
| chronic kidney disease | RTN3 | Rtn3* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | TTC21B | Ttc21b* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | TMEM67 | Tmem67* | 2 models | Alliance of Genome Resources | |||
| cystic kidney disease | SLIT2 | Slit2* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | ROBO1 | Robo1* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | LAMA5 | Lama5* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | EPHB4 | Ephb4* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | DNM2 | Dnm2* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | CEP290 | Cep290* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | BICC1 | Bicc1* | 1 model | Alliance of Genome Resources | |||
| cystic kidney disease | b2b2459Clo* | 1 model | |||||
| cystic kidney disease | b2b2059Clo* | 1 model | |||||
| cystic kidney disease | b2b1291Clo* | 1 model | |||||
| cystic kidney disease | b2b1291.2Clo* | 1 model | |||||
| cystic kidney disease | b2b1200Clo* | 1 model | |||||
| cystic kidney disease | b2b1200.2Clo* | 1 model | |||||
| cystic kidney disease | b2b1163Clo* | 1 model | |||||
| cystic kidney disease | b2b1146Clo* | 1 model | |||||
| cystic kidney disease | b2b243Clo* | 1 model | |||||
| cystic kidney disease | b2b243.2Clo* | 1 model | |||||
| Dent disease | CLCN5 | Clcn5* | 2 models | Alliance of Genome Resources | |||
| end stage renal disease | CD2AP | Cd2ap* | 1 model | Alliance of Genome Resources | |||
| Fanconi syndrome | HNF4A | Hnf4a* | 1 model | Alliance of Genome Resources | |||
| Fanconi syndrome | LRP2 | Lrp2* | 1 model | Alliance of Genome Resources | |||
| Fanconi syndrome | WHAMM | Whamm* | 1 model | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis | MIR193A | Mir193a* | 2 models | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis | CMAS | Cmas* | 1 model | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis | MYO9A | Myo9a* | 1 model | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis | SRGAP1 | Srgap1* | 1 model | Alliance of Genome Resources | |||
| focal segmental glomerulosclerosis | TNFAIP2 | Tnfaip2* | 1 model | Alliance of Genome Resources | |||
| Gitelman syndrome | STK39 | Stk39* | 3 models | Alliance of Genome Resources | |||
| Gitelman syndrome | WNK4 | Wnk4* | 1 model | Alliance of Genome Resources | |||
| glomerulonephritis | CFI | Cfi* | 1 model | Alliance of Genome Resources | |||
| IgA glomerulonephritis | WAS | Was* | 1 model | Alliance of Genome Resources | |||
| IgA glomerulonephritis | TNFSF14 | Tnfsf14* | 1 model | Alliance of Genome Resources | |||
| IgA glomerulonephritis | TNFSF13B | Tnfsf13b* | 1 model | Alliance of Genome Resources | |||
| IgA glomerulonephritis | B4GALT1 | B4galt1* | 1 model | Alliance of Genome Resources | |||
| kidney disease | UMOD | Umod* | 5 models | Alliance of Genome Resources | |||
| kidney disease | COL4A1 | Col4a1* | 2 models | Alliance of Genome Resources | |||
| membranoproliferative glomerulonephritis | TSLP | Tslp* | 1 model | Alliance of Genome Resources | |||
| membranoproliferative glomerulonephritis | CFH | Cfh*, Cfhr4 | 1 model | Alliance of Genome Resources | |||
| nephroblastoma | LIN28A | Lin28a* | 1 model | Alliance of Genome Resources | |||
| nephrocalcinosis | BRD4 | Brd4* | 1 model | Alliance of Genome Resources | |||
| nephrocalcinosis | POLG2 | Polg2* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | GRN | Grn* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | SIRT1 | Sirt1* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | AQP3 | Aqp3* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | UOX | Uox* | 1 model | Alliance of Genome Resources | |||
| nephrogenic diabetes insipidus | CLCNKA, CLCNKB | Clcnka*, Clcnkb | 1 model | Alliance of Genome Resources | |||
| nephronophthisis | WWTR1 | Wwtr1* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis | SDCCAG8 | Sdccag8* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis | CNTRL | Cntrl* | 1 model | Alliance of Genome Resources | |||
| nephronophthisis | AHI1 | Ahi1* | 2 models | Alliance of Genome Resources | |||
| nephrosis | LAMB2 | Lamb2* | 1 model | Alliance of Genome Resources | |||
| nephrotic syndrome | FAT1 | Fat1* | 1 model | Alliance of Genome Resources | |||
| nephrotic syndrome | NPHS2 | Nphs2* | 4 models | Alliance of Genome Resources | |||
| nephrotic syndrome | ITSN2 | Itsn2* | 1 model | Alliance of Genome Resources | |||
| nephrotic syndrome | MPV17 | Mpv17* | 1 model | Alliance of Genome Resources | |||
| nephrotic syndrome | NPHS1 | Nphs1* | 4 models | Alliance of Genome Resources | |||
| nephrotic syndrome | ARHGDIA | Arhgdia* | 1 model | Alliance of Genome Resources | |||
| nonpapillary renal cell carcinoma | FLCN | Flcn* | 1 model | Alliance of Genome Resources | |||
| obstructive nephropathy | MOCOS | Mocos* | 1 model | Alliance of Genome Resources | |||
| obstructive nephropathy | EXOC5 | Exoc5* | 1 model | Alliance of Genome Resources | |||
| oligomeganephronia | BCL2 | Bcl2* | 1 model | Alliance of Genome Resources | |||
| polycystic kidney disease | TULP3 | Tulp3* | 1 model | Alliance of Genome Resources | |||
| polycystic kidney disease | PTMA | Ptma* | 1 model | Alliance of Genome Resources | |||
| polycystic kidney disease | KIF3A | Kif3a* | 1 model | Alliance of Genome Resources | |||
| polycystic kidney disease | XYLT2 | Xylt2* | 1 model | Alliance of Genome Resources | |||
| pseudohypoaldosteronism | STK39 | Stk39* | 1 model | Alliance of Genome Resources | |||
| renal cell carcinoma | NF2 | Nf2* | 1 model | Alliance of Genome Resources | |||
| renal glycosuria | HNRNPF | Hnrnpf* | 1 model | Alliance of Genome Resources | |||
| urinary bladder cancer | CTNNB1 | Ctnnb1* | 4 models | Alliance of Genome Resources | |||
| urinary bladder cancer | NCSTN | Ncstn* | 2 models | Alliance of Genome Resources | |||
| urinary system disease | LZTS2 | Lzts2* | 1 model | Alliance of Genome Resources | |||
| urinary system disease | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
| urinary tract obstruction | ADAMTS1 | Adamts1* | 1 model | Alliance of Genome Resources | |||
| vesicoureteral reflux | UPK3A | Upk3a* | 1 model | Alliance of Genome Resources | |||
| | acute kidney failure | AGER* | Ager | Alliance of Genome Resources | |||
| acute kidney failure | AMBP* | Ambp | Alliance of Genome Resources | ||||
| acute kidney failure | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
| acute kidney failure | EPO* | Epo | Alliance of Genome Resources | ||||
| acute kidney failure | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| acute kidney failure | MPO* | Mpo | Alliance of Genome Resources | ||||
| acute kidney failure | PROC* | Proc | Alliance of Genome Resources | ||||
| acute kidney failure | SLC22A2* | Slc22a2 | Alliance of Genome Resources | ||||
| acute kidney failure | THBD* | Thbd | Alliance of Genome Resources | ||||
| acute kidney failure | CRP* | Crp | Alliance of Genome Resources | ||||
| acute pyelonephritis | CXCL8* | ||||||
| acute pyelonephritis | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
| anti-basement membrane glomerulonephritis | HLA-DPB1* | ||||||
| anti-basement membrane glomerulonephritis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| anti-basement membrane glomerulonephritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| anti-basement membrane glomerulonephritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | PKD1* | Pkd1 | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | MTOR* | Mtor | Alliance of Genome Resources | ||||
| autosomal dominant polycystic kidney disease | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
| Bartter disease | SLC12A1* | Slc12a1 | Alliance of Genome Resources | ||||
| Bartter disease | BSND* | Bsnd | Alliance of Genome Resources | ||||
| Bartter disease type 4b | CLCNKA*, CLCNKB* | Clcnka, Clcnkb | Alliance of Genome Resources | ||||
| Bartter disease type 5 | MAGED2* | Maged2 | Alliance of Genome Resources | ||||
| benign familial hematuria | COL4A4* | Col4a4 | Alliance of Genome Resources | ||||
| benign familial hematuria | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
| bladder carcinoma | PMF1*, PMF1-BGLAP | Pmf1 | Alliance of Genome Resources | ||||
| bladder disease | CHRM3* | Chrm3 | Alliance of Genome Resources | ||||
| bladder neck obstruction | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| bladder urothelial carcinoma | KDM6A* | Kdm6a | Alliance of Genome Resources | ||||
| CAKUT | NRIP1* | Nrip1 | Alliance of Genome Resources | ||||
| CAKUT | HSPA1B*, HSPA1A | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| CAKUT | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
| CAKUT1 | DSTYK* | Dstyk | Alliance of Genome Resources | ||||
| CAKUT2 | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
| CAKUT2 | TBX18* | Tbx18 | Alliance of Genome Resources | ||||
| calcium oxalate nephrolithiasis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| calcium oxalate nephrolithiasis | SLC26A1* | Slc26a1 | Alliance of Genome Resources | ||||
| calcium oxalate nephrolithiasis | OXGR1* | Oxgr1 | Alliance of Genome Resources | ||||
| calcium oxalate nephrolithiasis | FN1* | Fn1 | Alliance of Genome Resources | ||||
| calcium oxalate nephrolithiasis | CASR* | Casr | Alliance of Genome Resources | ||||
| chronic kidney disease | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
| chronic kidney disease | CPB2* | Cpb2 | Alliance of Genome Resources | ||||
| chronic kidney disease | APOC3* | Apoc3 | Alliance of Genome Resources | ||||
| chronic kidney disease | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
| chronic kidney disease | KLK1*, KLK2, KLK3 | Egfbp2, Klk1, Klk1b1, Klk1b3, Klk1b4, Klk1b5, Klk1b8, Klk1b9, Klk1b11, Klk1b16, Klk1b21, Klk1b22, Klk1b24, Klk1b26, Klk1b27 | Alliance of Genome Resources | ||||
| chronic kidney disease | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
| chronic kidney disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| chronic kidney disease | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| chronic kidney disease | AKAP12* | Akap12 | Alliance of Genome Resources | ||||
| chronic kidney disease | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
| chronic kidney disease | XDH* | Xdh | Alliance of Genome Resources | ||||
| chronic kidney disease | PTH* | Pth | Alliance of Genome Resources | ||||
| chronic kidney disease | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| chronic kidney disease | AGTR1* | Agtr1a, Agtr1b | Alliance of Genome Resources | ||||
| chronic kidney disease | AGER* | Ager | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | FTO* | Fto | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | MAP3K8* | Map3k8 | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | PAK6*, BUB1B-PAK6 | Pak6 | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | PPBP* | Ppbp | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | SETD2* | Setd2 | Alliance of Genome Resources | ||||
| clear cell renal cell carcinoma | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| crescentic glomerulonephritis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| cystic kidney disease | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
| cystitis | TLR5* | Tlr5 | Alliance of Genome Resources | ||||
| Dent disease 1 | CLCN5* | Clcn5 | Alliance of Genome Resources | ||||
| Dent disease 2 | OCRL* | Ocrl | Alliance of Genome Resources | ||||
| diabetes insipidus | AVP* | Avp | Alliance of Genome Resources | ||||
| diffuse cystic renal dysplasia | BICC1* | Bicc1 | Alliance of Genome Resources | ||||
| end stage renal disease | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| end stage renal disease | VWF* | Vwf | Alliance of Genome Resources | ||||
| end stage renal disease | UCP2* | Ucp2 | Alliance of Genome Resources | ||||
| end stage renal disease | SLC9A5* | Slc9a5 | Alliance of Genome Resources | ||||
| end stage renal disease | PPARG* | Pparg | Alliance of Genome Resources | ||||
| end stage renal disease | PLAU* | Plau | Alliance of Genome Resources | ||||
| end stage renal disease | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| end stage renal disease | NGF* | Ngf | Alliance of Genome Resources | ||||
| end stage renal disease | MYH9* | Myh9 | Alliance of Genome Resources | ||||
| end stage renal disease | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| end stage renal disease | MPO* | Mpo | Alliance of Genome Resources | ||||
| end stage renal disease | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
| end stage renal disease | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| end stage renal disease | ITGB3* | Itgb3 | Alliance of Genome Resources | ||||
| end stage renal disease | ITGA8* | Itga8 | Alliance of Genome Resources | ||||
| end stage renal disease | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| end stage renal disease | IL1A* | Il1a | Alliance of Genome Resources | ||||
| end stage renal disease | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| end stage renal disease | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| end stage renal disease | GLO1* | Glo1 | Alliance of Genome Resources | ||||
| end stage renal disease | GCKR* | Gckr | Alliance of Genome Resources | ||||
| end stage renal disease | FGB* | Fgb | Alliance of Genome Resources | ||||
| end stage renal disease | FABP2* | Fabp2 | Alliance of Genome Resources | ||||
| end stage renal disease | F5* | F5 | Alliance of Genome Resources | ||||
| end stage renal disease | ENPP1* | Enpp1 | Alliance of Genome Resources | ||||
| end stage renal disease | KLK1*, KLK2, KLK3 | Egfbp2, Klk1, Klk1b1, Klk1b3, Klk1b4, Klk1b5, Klk1b8, Klk1b9, Klk1b11, Klk1b16, Klk1b21, Klk1b22, Klk1b24, Klk1b26, Klk1b27 | Alliance of Genome Resources | ||||
| end stage renal disease | DRD2* | Drd2 | Alliance of Genome Resources | ||||
| end stage renal disease | CYP2C8*, CYP2C9, CYP2C18, CYP2C19 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c50, Cyp2c55, Cyp2c65, Cyp2c66 | Alliance of Genome Resources | ||||
| end stage renal disease | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| end stage renal disease | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
| end stage renal disease | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| end stage renal disease | COL4A4* | Col4a4 | Alliance of Genome Resources | ||||
| end stage renal disease | COL4A3* | Col4a3 | Alliance of Genome Resources | ||||
| end stage renal disease | COL3A1* | Col3a1 | Alliance of Genome Resources | ||||
| end stage renal disease | CHGA* | Chga | Alliance of Genome Resources | ||||
| end stage renal disease | CD40* | Cd40 | Alliance of Genome Resources | ||||
| end stage renal disease | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
| end stage renal disease | BDKRB1* | Bdkrb1 | Alliance of Genome Resources | ||||
| end stage renal disease | AGTR2* | Agtr2 | Alliance of Genome Resources | ||||
| end stage renal disease | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
| end stage renal disease | ACE* | Ace | Alliance of Genome Resources | ||||
| familial juvenile hyperuricemic nephropathy | MUC1* | Muc1 | Alliance of Genome Resources | ||||
| familial juvenile hyperuricemic nephropathy | SEC61A1* | Sec61a1 | Alliance of Genome Resources | ||||
| familial juvenile hyperuricemic nephropathy | REN* | Ren1, Ren2 | Alliance of Genome Resources | ||||
| familial nephrotic syndrome | LAMA5* | Lama5 | Alliance of Genome Resources | ||||
| familial nephrotic syndrome | DAAM2* | Daam2 | Alliance of Genome Resources | ||||
| Fanconi renotubular syndrome 1 | GATM* | Gatm | Alliance of Genome Resources | ||||
| Fanconi renotubular syndrome 2 | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
| Fanconi renotubular syndrome 3 | EHHADH* | Ehhadh | Alliance of Genome Resources | ||||
| Fanconi renotubular syndrome 4 | HNF4A* | Hnf4a | Alliance of Genome Resources | ||||
| Fanconi renotubular syndrome 5 | NDUFAF6* | Ndufaf6 | Alliance of Genome Resources | ||||
| Fanconi syndrome | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis | ACTN4* | Actn4 | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis | CD2AP* | Cd2ap | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis | TRPC6* | Trpc6 | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis 5 | INF2* | Inf2 | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis 6 | MYO1E* | Myo1e | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis 7 | PAX2* | Pax2 | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis 8 | ANLN* | Anln | Alliance of Genome Resources | ||||
| focal segmental glomerulosclerosis 9 | CRB2* | Crb2 | Alliance of Genome Resources | ||||
| Gitelman syndrome | CLCNKB*, CLCNKA | Clcnka, Clcnkb | Alliance of Genome Resources | ||||
| glomerulonephritis | CNDP1* | Cndp1 | Alliance of Genome Resources | ||||
| glomerulonephritis | C1QA* | C1qa | Alliance of Genome Resources | ||||
| glomerulonephritis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| glomerulonephritis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| glomerulonephritis | SCGB1A1* | Scgb1a1 | Alliance of Genome Resources | ||||
| glomerulonephritis | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
| glomerulonephritis | TPO* | Tpo | Alliance of Genome Resources | ||||
| glomerulonephritis | GDNF* | Gdnf | Alliance of Genome Resources | ||||
| glomerulonephritis | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| glomerulonephritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| glomerulonephritis | FCGR2B*, FCGR2A, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| glomerulonephritis | F2* | F2 | Alliance of Genome Resources | ||||
| glomerulosclerosis | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
| glomerulosclerosis | HBEGF* | Hbegf | Alliance of Genome Resources | ||||
| granulomatosis with polyangiitis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
| granulomatosis with polyangiitis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| granulomatosis with polyangiitis | FCAR* | ||||||
| granulomatosis with polyangiitis | IL10* | Il10 | Alliance of Genome Resources | ||||
| granulomatosis with polyangiitis | VTN* | Vtn | Alliance of Genome Resources | ||||
| Hantavirus hemorrhagic fever with renal syndrome | HLA-DRB1*, HLA-DRB5*, HLA-DRB3, HLA-DRB4 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | C1GALT1C1* | C1galt1c1 | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | CD36* | Cd36 | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | CD46* | Cd46 | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| hemolytic-uremic syndrome | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
| hydronephrosis | AGT* | Agt | Alliance of Genome Resources | ||||
| hypophosphatemic nephrolithiasis/osteoporosis 1 | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
| hypophosphatemic nephrolithiasis/osteoporosis 2 | NHERF1* | Nherf1 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | ACE* | Ace | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | SPRY2* | Spry2 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | ADD1* | Add1 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | ACSM3* | Acsm3 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | FCAR* | ||||||
| IgA glomerulonephritis | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | CHGA* | Chga | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | CFB* | Cfb | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | CD14* | Cd14 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | AGTR2* | Agtr2 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | ADD2* | Add2 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | SERPINB7* | Serpinb7 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | SELL* | Sell | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | SELE* | Sele | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | TNFRSF1A* | Tnfrsf1a | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | TLR1* | Tlr1 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | STAT4* | Stat4 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | PDE5A* | Pde5a | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | NGF* | Ngf | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | MUC20* | Muc20 | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | MTR* | Mtr | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | IL1B* | Il1b | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
| IgA glomerulonephritis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| iminoglycinuria | SLC36A2* | Slc36a2 | Alliance of Genome Resources | ||||
| interstitial cystitis | CSF1* | Csf1 | Alliance of Genome Resources | ||||
| interstitial cystitis | NGF* | Ngf | Alliance of Genome Resources | ||||
| interstitial cystitis | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
| interstitial nephritis | CRP* | Crp | Alliance of Genome Resources | ||||
| kidney angiomyolipoma | MTOR* | Mtor | Alliance of Genome Resources | ||||
| kidney cancer | FGF9* | Fgf9 | Alliance of Genome Resources | ||||
| kidney disease | LIPC* | Lipc | Alliance of Genome Resources | ||||
| kidney disease | HNF1B* | Hnf1b | Alliance of Genome Resources | ||||
| kidney disease | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| kidney disease | CEP290* | Cep290 | Alliance of Genome Resources | ||||
| kidney disease | ALOX5AP* | Alox5ap | Alliance of Genome Resources | ||||
| kidney disease | VPS33B* | Vps33b | Alliance of Genome Resources | ||||
| kidney failure | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| kidney failure | GFER* | Gfer | Alliance of Genome Resources | ||||
| kidney failure | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| kidney failure | DRD1* | Drd1 | Alliance of Genome Resources | ||||
| Liddle syndrome | SCNN1A* | Scnn1a | Alliance of Genome Resources | ||||
| Liddle syndrome | SCNN1G* | Scnn1g | Alliance of Genome Resources | ||||
| lipoid nephrosis | STAT6* | Stat6 | Alliance of Genome Resources | ||||
| low molecular weight proteinuria with hypercalciuric nephrocalcinosis | CLCN5* | Clcn5 | Alliance of Genome Resources | ||||
| lupus nephritis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| lupus nephritis | IFNG* | Ifng | Alliance of Genome Resources | ||||
| lupus nephritis | ITGAM* | Itgam | Alliance of Genome Resources | ||||
| lupus nephritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| lupus nephritis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| lupus nephritis | MPO* | Mpo | Alliance of Genome Resources | ||||
| lupus nephritis | PDCD1* | Pdcd1 | Alliance of Genome Resources | ||||
| lupus nephritis | SNRPE* | Snrpe, Snrpert | Alliance of Genome Resources | ||||
| lupus nephritis | KLKB1* | Klkb1 | Alliance of Genome Resources | ||||
| lupus nephritis | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
| lupus nephritis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
| lupus nephritis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| lupus nephritis | CRP* | Crp | Alliance of Genome Resources | ||||
| lupus nephritis | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
| lupus nephritis | CD40LG* | Cd40lg | Alliance of Genome Resources | ||||
| lupus nephritis | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
| lupus nephritis | AGER* | Ager | Alliance of Genome Resources | ||||
| lupus nephritis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| membranoproliferative glomerulonephritis | CFB* | Cfb | Alliance of Genome Resources | ||||
| membranoproliferative glomerulonephritis | FN1* | Fn1 | Alliance of Genome Resources | ||||
| membranous glomerulonephritis | MME* | Mme | Alliance of Genome Resources | ||||
| membranous glomerulonephritis | CFB* | Cfb | Alliance of Genome Resources | ||||
| membranous glomerulonephritis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| nephritis | SNRPD1* | Snrpd1 | Alliance of Genome Resources | ||||
| nephritis | FOXC2* | Foxc2 | Alliance of Genome Resources | ||||
| nephritis | ACE* | Ace | Alliance of Genome Resources | ||||
| nephritis | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| nephritis | PARP1* | Parp1 | Alliance of Genome Resources | ||||
| nephroblastoma | REST* | Rest | Alliance of Genome Resources | ||||
| nephroblastoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| nephroblastoma | IGF2R* | Igf2r | Alliance of Genome Resources | ||||
| nephroblastoma | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
| nephroblastoma | SIX1* | Six1 | Alliance of Genome Resources | ||||
| nephroblastoma | POU6F2* | Pou6f2 | Alliance of Genome Resources | ||||
| nephroblastoma | CTNNB1* | Ctnnb1 | Alliance of Genome Resources | ||||
| nephroblastoma | DIS3L2* | Dis3l2 | Alliance of Genome Resources | ||||
| nephroblastoma | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| nephroblastoma | WT1* | Wt1 | 1 model | Alliance of Genome Resources | |||
| nephroblastoma | GPC3* | Gpc3 | Alliance of Genome Resources | ||||
| nephroblastoma | H19* | ||||||
| nephroblastoma | TP73* | Trp73 | Alliance of Genome Resources | ||||
| nephroblastoma | TIMP4* | Timp4 | Alliance of Genome Resources | ||||
| nephrogenic diabetes insipidus type 2 | AQP2* | Aqp2 | Alliance of Genome Resources | ||||
| nephrogenic syndrome of inappropriate antidiuresis | AVPR2* | Avpr2 | Alliance of Genome Resources | ||||
| nephrolithiasis | CASR* | Casr | Alliance of Genome Resources | ||||
| nephrolithiasis | RGS14* | Rgs14 | Alliance of Genome Resources | ||||
| nephrolithiasis | SLC34A1* | Slc34a1 | Alliance of Genome Resources | ||||
| nephroma | DICER1* | Dicer1 | Alliance of Genome Resources | ||||
| nephronophthisis | NPHP1* | Nphp1 | Alliance of Genome Resources | ||||
| nephronophthisis | IQCB1* | Iqcb1 | Alliance of Genome Resources | ||||
| nephronophthisis | NPHP3* | Nphp3 | Alliance of Genome Resources | ||||
| nephronophthisis | NPHP4* | Nphp4 | Alliance of Genome Resources | ||||
| nephronophthisis | RPGRIP1L* | Rpgrip1l | Alliance of Genome Resources | ||||
| nephronophthisis | SLC41A1* | Slc41a1 | Alliance of Genome Resources | ||||
| nephronophthisis | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
| nephronophthisis 11 | TMEM67* | Tmem67 | Alliance of Genome Resources | ||||
| nephronophthisis 12 | TTC21B* | Ttc21b | Alliance of Genome Resources | ||||
| nephronophthisis 13 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
| nephronophthisis 14 | ZNF423* | Zfp423 | Alliance of Genome Resources | ||||
| nephronophthisis 15 | CEP164* | Cep164 | Alliance of Genome Resources | ||||
| nephronophthisis 16 | ANKS6* | Anks6 | Alliance of Genome Resources | ||||
| nephronophthisis 18 | CEP83* | Cep83 | Alliance of Genome Resources | ||||
| nephronophthisis 19 | DCDC2* | Dcdc2a | Alliance of Genome Resources | ||||
| nephronophthisis 20 | MAPKBP1* | Mapkbp1 | Alliance of Genome Resources | ||||
| nephronophthisis 9 | NEK8* | Nek8 | Alliance of Genome Resources | ||||
| nephronophthisis-like nephropathy 1 | XPNPEP3* | Xpnpep3 | Alliance of Genome Resources | ||||
| nephrosclerosis | ADRB1* | Adrb1 | Alliance of Genome Resources | ||||
| nephrosclerosis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| nephrosis | GATA3* | Gata3 | Alliance of Genome Resources | ||||
| nephrotic syndrome | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| nephrotic syndrome | PLCE1* | Plce1 | Alliance of Genome Resources | ||||
| nephrotic syndrome | ALB* | Alb | Alliance of Genome Resources | ||||
| nephrotic syndrome | EPO* | Epo | Alliance of Genome Resources | ||||
| nephrotic syndrome | IL1B* | Il1b | Alliance of Genome Resources | ||||
| nephrotic syndrome type 1 | NPHS1* | Nphs1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 10 | EMP2* | Emp2 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 11 | NUP107* | Nup107 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 12 | NUP93* | Nup93 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 13 | NUP205* | Nup205 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 14 | SGPL1* | Sgpl1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 15 | MAGI2* | Magi2 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 16 | KANK2* | Kank2 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 17 | NUP85* | Nup85 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 18 | NUP133* | Nup133 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 19 | NUP160* | Nup160 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 2 | NPHS2* | Nphs2 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 2 | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 2 | PLCE1* | Plce1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 2 | TRPC6* | Trpc6 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 20 | TBC1D8B* | Tbc1d8b | Alliance of Genome Resources | ||||
| nephrotic syndrome type 21 | AVIL* | Avil | Alliance of Genome Resources | ||||
| nephrotic syndrome type 22 | NOS1AP* | Nos1ap | Alliance of Genome Resources | ||||
| nephrotic syndrome type 23 | KIRREL1* | Kirrel1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 3 | PLCE1* | Plce1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 4 | WT1* | Wt1 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 5 | LAMB2* | Lamb2 | Alliance of Genome Resources | ||||
| nephrotic syndrome type 6 | PTPRO* | Ptpro | Alliance of Genome Resources | ||||
| nephrotic syndrome type 7 | DGKE* | Dgke | Alliance of Genome Resources | ||||
| nephrotic syndrome type 8 | ARHGDIA* | Arhgdia | Alliance of Genome Resources | ||||
| nephrotic syndrome type 9 | COQ8B* | Coq8b | Alliance of Genome Resources | ||||
| overactive bladder syndrome | PENK* | Penk | Alliance of Genome Resources | ||||
| overactive bladder syndrome | NGF* | Ngf | Alliance of Genome Resources | ||||
| papillary renal cell carcinoma | PRCC* | Prcc | Alliance of Genome Resources | ||||
| papillary renal cell carcinoma | MET* | Met | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | C3* | C3 | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | C5* | Hc | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | PIGT* | Pigt | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | PIGA* | Piga | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| paroxysmal nocturnal hemoglobinuria | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| polycystic kidney disease | GANAB* | Ganab | Alliance of Genome Resources | ||||
| polycystic kidney disease | PKD2* | Pkd2 | Alliance of Genome Resources | ||||
| polycystic kidney disease 3 | GANAB* | Ganab | Alliance of Genome Resources | ||||
| polycystic kidney disease 5 | DZIP1L* | Dzip1l | Alliance of Genome Resources | ||||
| polycystic kidney disease 6 | DNAJB11* | Dnajb11 | Alliance of Genome Resources | ||||
| polycystic kidney disease 7 | ALG5* | Alg5 | Alliance of Genome Resources | ||||
| Polyomavirus-associated nephropathy | KIR3DS1*, KIR2DL1, KIR2DL2, KIR2DL3, KIR2DL4, KIR2DL5A, KIR2DL5B, KIR2DP1, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2, KIR3DL3, KIR3DP1 | Kir3dl1, Kir3dl2 | Alliance of Genome Resources | ||||
| proteinuria | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| proteinuria | ACE* | Ace | Alliance of Genome Resources | ||||
| proteinuria | AGER* | Ager | Alliance of Genome Resources | ||||
| proteinuria | MYH9* | Myh9 | Alliance of Genome Resources | ||||
| proteinuria | PLA2G7* | Pla2g7 | Alliance of Genome Resources | ||||
| proteinuria | SNRPD1* | Snrpd1 | Alliance of Genome Resources | ||||
| proteinuria | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
| pseudohypoaldosteronism | SCNN1G* | Scnn1g | Alliance of Genome Resources | ||||
| pseudohypoaldosteronism | SCNN1B* | Scnn1b | Alliance of Genome Resources | ||||
| pseudohypoaldosteronism | SCNN1A* | Scnn1a | Alliance of Genome Resources | ||||
| pseudohypoaldosteronism | NR3C2* | Nr3c2 | Alliance of Genome Resources | ||||
| pseudohypoaldosteronism | CUL3* | Cul3 | 2 "NOT" models | Alliance of Genome Resources | |||
| pseudohypoaldosteronism | WNK1* | Wnk1 | Alliance of Genome Resources | ||||
| pyelonephritis | TLR1* | Tlr1 | Alliance of Genome Resources | ||||
| pyelonephritis | CXCR1* | Cxcr1 | Alliance of Genome Resources | ||||
| renal agenesis | GFRA1* | Gfra1 | Alliance of Genome Resources | ||||
| renal agenesis | GREB1L* | Greb1l | Alliance of Genome Resources | ||||
| renal agenesis | ITGA8* | Itga8 | Alliance of Genome Resources | ||||
| renal agenesis | FGF20* | Fgf20 | Alliance of Genome Resources | ||||
| renal cell carcinoma | COMT* | Comt | Alliance of Genome Resources | ||||
| renal cell carcinoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| renal cell carcinoma | CDK2* | Cdk2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CA9* | Car9 | Alliance of Genome Resources | ||||
| renal cell carcinoma | C4A*, C4B*, C4B_2 | C4a, C4b | Alliance of Genome Resources | ||||
| renal cell carcinoma | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | ATP5MC2* | Atp5mc2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | ARNT* | Arnt | Alliance of Genome Resources | ||||
| renal cell carcinoma | APC* | Apc | Alliance of Genome Resources | ||||
| renal cell carcinoma | AKT3* | Akt3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
| renal cell carcinoma | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | RELA* | Rela | Alliance of Genome Resources | ||||
| renal cell carcinoma | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | RNF139* | Rnf139 | Alliance of Genome Resources | ||||
| renal cell carcinoma | SLC49A4* | Slc49a4 | Alliance of Genome Resources | ||||
| renal cell carcinoma | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | TFE3* | Tfe3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | THRA* | Thra | Alliance of Genome Resources | ||||
| renal cell carcinoma | THRB* | Thrb | Alliance of Genome Resources | ||||
| renal cell carcinoma | TNF* | Tnf | Alliance of Genome Resources | ||||
| renal cell carcinoma | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| renal cell carcinoma | TP73* | Trp73 | Alliance of Genome Resources | ||||
| renal cell carcinoma | VHL*, VHLL | Vhl | Alliance of Genome Resources | ||||
| renal cell carcinoma | WIF1* | Wif1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
| renal cell carcinoma | PDGFRB* | Pdgfrb | Alliance of Genome Resources | ||||
| renal cell carcinoma | PBRM1* | Pbrm1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | PAK1* | Pak1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | NR3C1* | Nr3c1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| renal cell carcinoma | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| renal cell carcinoma | MET* | Met | Alliance of Genome Resources | ||||
| renal cell carcinoma | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | MAP2K1* | Map2k1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | MANF* | Manf | Alliance of Genome Resources | ||||
| renal cell carcinoma | LTF* | Ltf | Alliance of Genome Resources | ||||
| renal cell carcinoma | KIT* | Kit | Alliance of Genome Resources | ||||
| renal cell carcinoma | KDM4C* | Kdm4c | Alliance of Genome Resources | ||||
| renal cell carcinoma | JUP* | Jup | Alliance of Genome Resources | ||||
| renal cell carcinoma | IL4R* | Il4ra | Alliance of Genome Resources | ||||
| renal cell carcinoma | IL2* | Il2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| renal cell carcinoma | HOXB13* | Hoxb13 | Alliance of Genome Resources | ||||
| renal cell carcinoma | HNF1B* | Hnf1b | Alliance of Genome Resources | ||||
| renal cell carcinoma | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
| renal cell carcinoma | HAVCR2* | Havcr2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| renal cell carcinoma | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| renal cell carcinoma | FTO* | Fto | Alliance of Genome Resources | ||||
| renal cell carcinoma | FLCN* | Flcn | Alliance of Genome Resources | ||||
| renal cell carcinoma | FHIT* | Fhit | Alliance of Genome Resources | ||||
| renal cell carcinoma | FAS* | Fas | Alliance of Genome Resources | ||||
| renal cell carcinoma | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | EGLN3* | Egln3 | Alliance of Genome Resources | ||||
| renal cell carcinoma | EGLN2* | Egln2 | Alliance of Genome Resources | ||||
| renal cell carcinoma | EGLN1* | Egln1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| renal cell carcinoma | CSF1R* | Csf1r | Alliance of Genome Resources | ||||
| renal fibrosis | GFER* | Gfer | Alliance of Genome Resources | ||||
| renal fibrosis | CRP* | Crp | Alliance of Genome Resources | ||||
| renal fibrosis | FCAR* | ||||||
| renal fibrosis | CYP2J2* | Cyp2j5, Cyp2j6, Cyp2j7, Cyp2j8, Cyp2j9, Cyp2j11, Cyp2j12, Cyp2j13 | Alliance of Genome Resources | ||||
| renal fibrosis | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| renal glycosuria | SLC5A2* | Slc5a2 | Alliance of Genome Resources | ||||
| renal hypertension | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
| renal hypertension | CYP2J2* | Cyp2j5, Cyp2j6, Cyp2j7, Cyp2j8, Cyp2j9, Cyp2j11, Cyp2j12, Cyp2j13 | Alliance of Genome Resources | ||||
| renal hypertension | CYP2C8*, CYP2C9, CYP2C18, CYP2C19 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c50, Cyp2c55, Cyp2c65, Cyp2c66 | Alliance of Genome Resources | ||||
| renal hypertension | NPPA* | Nppa | Alliance of Genome Resources | ||||
| renal hypertension | HSPA8* | Hspa8 | Alliance of Genome Resources | ||||
| renal hypoplasia | RET* | Ret | Alliance of Genome Resources | ||||
| renal tuberculosis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
| renal tubular acidosis | ATP6V1B1* | Atp6v1b1 | Alliance of Genome Resources | ||||
| renal tubular transport disease | AUH* | Auh | Alliance of Genome Resources | ||||
| renal tubular transport disease | CLDN16* | Cldn16 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | BMI1*, COMMD3-BMI1 | Bmi1 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | PAX2* | Pax2 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | SALL1* | Sall1 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | SIX2* | Six2 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | SUZ12* | Suz12 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | TEK* | Tek | Alliance of Genome Resources | ||||
| renal Wilms' tumor | WT1* | Wt1 | Alliance of Genome Resources | ||||
| renal Wilms' tumor | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| renal Wilms' tumor | H19* | ||||||
| rhabdoid cancer | SMARCB1* | Smarcb1 | Alliance of Genome Resources | ||||
| rhabdoid cancer | SMARCA4* | Smarca4 | Alliance of Genome Resources | ||||
| uremia | COMT* | Comt | Alliance of Genome Resources | ||||
| ureteral obstruction | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| urethral obstruction | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| uric acid nephrolithiasis | ZNF365* | Zfp365 | Alliance of Genome Resources | ||||
| urinary bladder cancer | H19* | ||||||
| urinary bladder cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | KDR* | Kdr | Alliance of Genome Resources | ||||
| urinary bladder cancer | KRAS* | Kras | 1 model | Alliance of Genome Resources | |||
| urinary bladder cancer | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
| urinary bladder cancer | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| urinary bladder cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| urinary bladder cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| urinary bladder cancer | FHIT* | Fhit | Alliance of Genome Resources | ||||
| urinary bladder cancer | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
| urinary bladder cancer | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | FGF1* | Fgf1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | FASLG* | Fasl | Alliance of Genome Resources | ||||
| urinary bladder cancer | FAS* | Fas | Alliance of Genome Resources | ||||
| urinary bladder cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| urinary bladder cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | DAPK1* | Dapk1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CYP2C9*, CYP2C8, CYP2C18, CYP2C19 | Cyp2c29, Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c50, Cyp2c55, Cyp2c65, Cyp2c66 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CXCR2* | Cxcr2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDKN2B* | Cdkn2b | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDK1* | Cdk1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
| urinary bladder cancer | CASP9* | Casp9 | Alliance of Genome Resources | ||||
| urinary bladder cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
| urinary bladder cancer | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | AXIN1* | Axin1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | ATP5MC2* | Atp5mc2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | AMACR* | Amacr | Alliance of Genome Resources | ||||
| urinary bladder cancer | MIR494* | Mir494 | Alliance of Genome Resources | ||||
| urinary bladder cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| urinary bladder cancer | MRE11* | Mre11a | Alliance of Genome Resources | ||||
| urinary bladder cancer | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| urinary bladder cancer | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| urinary bladder cancer | HRAS* | Hras | Alliance of Genome Resources | ||||
| urinary bladder cancer | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | SOX4* | Sox4 | Alliance of Genome Resources | ||||
| urinary bladder cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | TERT* | Tert | Alliance of Genome Resources | ||||
| urinary bladder cancer | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | TIMP3* | Timp3 | Alliance of Genome Resources | ||||
| urinary bladder cancer | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | TMEFF2* | Tmeff2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| urinary bladder cancer | WIF1* | Wif1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | XDH* | Xdh | Alliance of Genome Resources | ||||
| urinary bladder cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | IL2* | Il2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | MSH2* | Msh2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | ATP8* | mt-Atp8 | Alliance of Genome Resources | ||||
| urinary bladder cancer | CYTB* | mt-Cytb | Alliance of Genome Resources | ||||
| urinary bladder cancer | ND2* | mt-Nd2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| urinary bladder cancer | MTR* | Mtr | Alliance of Genome Resources | ||||
| urinary bladder cancer | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
| urinary bladder cancer | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| urinary bladder cancer | PLAU* | Plau | Alliance of Genome Resources | ||||
| urinary bladder cancer | PLK1* | Plk1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | PMF1*, PMF1-BGLAP | Pmf1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
| urinary bladder cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| urinary bladder cancer | RB1* | Rb1 | 1 model | Alliance of Genome Resources | |||
| urinary bladder cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| urinary schistosomiasis | STAT6* | Stat6 | Alliance of Genome Resources | ||||
| urinary schistosomiasis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| urinary system cancer | NQO1* | Nqo1 | Alliance of Genome Resources | ||||
| urinary system cancer | WNT2* | Wnt2 | Alliance of Genome Resources | ||||
| urinary tract infection | CXCR1* | Cxcr1 | Alliance of Genome Resources | ||||
| urinary tract infection | LCN2* | Lcn2 | Alliance of Genome Resources | ||||
| urinary tract infection | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
| urinary tract infection | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
| urinary tract infection | CXCL8* | ||||||
| urinary tract infection | HSPA1B*, HSPA1A | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
| urolithiasis | PLAU* | Plau | Alliance of Genome Resources | ||||
| vesicoureteral reflux | TNXB* | Tnxb | Alliance of Genome Resources | ||||
| vesicoureteral reflux | SOX17* | Sox17 | Alliance of Genome Resources | ||||
| vesicoureteral reflux | ROBO2* | Robo2 | Alliance of Genome Resources | ||||
| vesicoureteral reflux | IFNG* | Ifng | Alliance of Genome Resources | ||||
| vesicoureteral reflux | AGTR2* | Agtr2 | Alliance of Genome Resources | ||||
| X-linked nephrolithiasis type I | CLCN5* | Clcn5 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| autosomal dominant polycystic kidney disease | Tg(HBB-Myc)#Cos | 1 model | |
| autosomal recessive polycystic kidney disease | T(2;10)67Gso | 1 model | |
| autosomal recessive polycystic kidney disease | Tg(Pkd1)26Mtru | 1 model | |
| cystic kidney disease | Tg(Pklr-HRAS*G12V)21Ak | 1 model | |
| cystic kidney disease | Tg(tetO-MYC)36aBop | 1 model | |
| familial juvenile hyperuricemic nephropathy | Tg(Umod*C217G)1Xrw | 1 model | |
| familial juvenile hyperuricemic nephropathy | Tg(Umod*C147W)958Lura | 1 model | |
| focal segmental glomerulosclerosis | Tg(Thy1/THY1)T6Gsv | 1 model | |
| focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*E896K)F75aWalz | 1 model | |
| focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6)F419Walz | 1 model | |
| focal segmental glomerulosclerosis 2 | Tg(NPHS2-Trpc6*P111Q)F615Walz | 1 model | |
| hemolytic-uremic syndrome | Tg(CAG-Cfh*)#Mcp | 1 model | |
| IgA glomerulonephritis | Tg(Itgam-FCAR)83Rcmo | 1 model | |
| IgA glomerulonephritis | Tg(Lck-Tnfsf14)24Yxf | 1 model | |
| IgA glomerulonephritis | Tg(MMTV-Scgb1a1)#Abm | 1 model | |
| IgA glomerulonephritis | Tg(Tnfsf13b)1Fma | 1 model | |
| kidney disease | mgb | 1 model | |
| kidney disease | Tg(tetO-GFP,-APOL1*)#Susz | 1 model | |
| kidney disease | Tg(tetO-GFP,-APOL1*S342G*I384M)#Susz | 1 model | |
| kidney disease | Tg(Umod*C147W)958Lura | 1 model | |
| membranoproliferative glomerulonephritis | Tg(Lck-Tslp)1Chea | 1 model | |
| nephroblastoma | Tg(EIF1AX-Lin28a)#Gqda | 1 model | |
| polycystic kidney disease | Tg(Actb-Ptma)T12Clwu | 1 model | |
| polycystic kidney disease 1 | Tg(Pkd1*)39Mtru | 2 models | |
| polycystic kidney disease 2 | Tg(CAG-PKD2)#Hwl | 1 model | |
| urinary bladder cancer | Tg(CAG-TRIM29)ADims | 1 model | |
| urinary bladder cancer | Tg(KRT19-TAg)7Eps | 1 model | |
| urinary bladder cancer | Tg(UPII-SV40T)2Xrw | 1 model | |
| urinary bladder cancer | Tg(UPII-SV40T)29Xrw | 1 model | |
| urinary bladder cancer | Tg(Upk2-TAg)1Rkl | 1 model | |